Search research articles
Contact Us
Filters
Showing results (11-20 of 466) with videos related to
Page
of 47
Sort By:
Current Opinion in Infectious Diseases
|
January 30, 2025
Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies
Alice Toschi, Maddalena Giannella, Pierluigi Viale
Current Opinion in Infectious Diseases
|
August 9, 2022
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?
Maddalena Giannella, Renato Pascale, Pierluigi Viale
Current Opinion in Infectious Diseases
|
November 6, 2023
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Federica Cosentino, Pierluigi Viale, Maddalena Giannella
Le Infezioni in Medicina
|
September 13, 2023
<i>Candida auris:</i> the new fungal threat
Francesco Pallotta, Pierluigi Viale, Francesco Barchiesi
Current Opinion in Pulmonary Medicine
|
April 9, 2005
Nosocomial pulmonary infections in HIV-positive patients
Nicola Petrosillo, Emanuele Nicastri, Pierluigi Viale
Clinical Pharmacokinetics
|
September 24, 2005
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
Federico Pea, Pierluigi Viale, Mario Furlanut
Infectious Disease Clinics of North America
|
May 27, 2023
Antimicrobial Resistance in Organ Transplant Recipients
Maddalena Giannella, Matteo Rinaldi, Pierluigi Viale
Current Infectious Disease Reports
|
April 2, 2008
Liver transplant in patients with HIV: infection risk associated with HIV and post-transplant immunosuppression
Pierluigi Viale, Umberto Baccarani, Marcello Tavio
The Journal of Antimicrobial Chemotherapy
|
November 29, 2023
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run
Milo Gatti, Pierluigi Viale, Federico Pea
Expert Opinion on Drug Metabolism & Toxicology
|
January 28, 2018
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia
Marco Falcone, Pierluigi Viale, Giusy Tiseo, et al.
Page
of 47
Search research articles
Search
Showing results (11-20 of 466) with videos related to
Sort By:
Page
of 47
Current Opinion in Infectious Diseases
|
January 30, 2025
Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies
Alice Toschi, Maddalena Giannella, Pierluigi Viale
Current Opinion in Infectious Diseases
|
August 9, 2022
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?
Maddalena Giannella, Renato Pascale, Pierluigi Viale
Current Opinion in Infectious Diseases
|
November 6, 2023
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Federica Cosentino, Pierluigi Viale, Maddalena Giannella
Le Infezioni in Medicina
|
September 13, 2023
<i>Candida auris:</i> the new fungal threat
Francesco Pallotta, Pierluigi Viale, Francesco Barchiesi
Current Opinion in Pulmonary Medicine
|
April 9, 2005
Nosocomial pulmonary infections in HIV-positive patients
Nicola Petrosillo, Emanuele Nicastri, Pierluigi Viale
Clinical Pharmacokinetics
|
September 24, 2005
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
Federico Pea, Pierluigi Viale, Mario Furlanut
Infectious Disease Clinics of North America
|
May 27, 2023
Antimicrobial Resistance in Organ Transplant Recipients
Maddalena Giannella, Matteo Rinaldi, Pierluigi Viale
Current Infectious Disease Reports
|
April 2, 2008
Liver transplant in patients with HIV: infection risk associated with HIV and post-transplant immunosuppression
Pierluigi Viale, Umberto Baccarani, Marcello Tavio
The Journal of Antimicrobial Chemotherapy
|
November 29, 2023
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run
Milo Gatti, Pierluigi Viale, Federico Pea
Expert Opinion on Drug Metabolism & Toxicology
|
January 28, 2018
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia
Marco Falcone, Pierluigi Viale, Giusy Tiseo, et al.
Page
of 47